PubMed

Recent developments in targeting access to high cost medicines in Australia.

Lu CY, Ritchie J, Williams KM, Day RO.

Aust New Zealand Health Policy. 2005 Nov 23;2:28.PMID: 16305742 [PubMed]Related articlesFree article

The views of stakeholders on controlled access schemes for high-cost antirheumatic biological medicines in Australia.

Lu CY, Ritchie J, Williams K, Day R.

Aust New Zealand Health Policy. 2007 Dec 20;4:26.PMID: 18096055 [PubMed - in process]Related articlesFree article

New medicines in primary care: a review of influences on general practitioner prescribing.

Mason A.

J Clin Pharm Ther. 2008 Feb;33(1):1-10. Review.PMID: 18211610 [PubMed - indexed for MEDLINE]Related articles

Access to high cost medicines in Australia: ethical perspectives.

Lu CY, Macneill P, Williams K, Day R.

Aust New Zealand Health Policy. 2008 May 19;5:4.PMID: 18489760 [PubMed - in process]Related articlesFree article

The funding and use of high-cost medicines in Australia: the example of anti-rheumatic biological medicines.

Lu CY, Williams KM, Day RO.

Aust New Zealand Health Policy. 2007 Mar 1;4:2.PMID: 17331230 [PubMed]Related articlesFree article

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29.PMID: 18987905 [PubMed - indexed for MEDLINE]Related articles

Framing access to medicines in developing countries: an analysis of media coverage of Canada's Access to Medicines Regime.

Esmail LC, Phillips K, Kuek V, Cosio AP, Kohler JC.

BMC Int Health Hum Rights. 2010 Jan 4;10:1.PMID: 20044940 [PubMed - in process]Related articlesFree article

Access to tumour necrosis factor inhibitors for rheumatoid arthritis treatment under the Australian Pharmaceutical Benefits Scheme: are we on target?

Lu CY, Williams KM, Day RO.

Intern Med J. 2006 Jan;36(1):19-27.PMID: 16409309 [PubMed - indexed for MEDLINE]Related articles

Has the use of disease-modifying anti-rheumatic drugs changed as a consequence of controlled access to high-cost biological agents through the Pharmaceutical Benefits Scheme?

Lu CY, Williams KM, Day RO.

Intern Med J. 2007 Sep;37(9):601-6. Epub 2007 Jun 2.PMID: 17542999 [PubMed - indexed for MEDLINE]Related articles

Stakeholders' views of UK nurse and pharmacist supplementary prescribing.

Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, Lymn J, Murphy E, Ratcliffe J, Ward P.

J Health Serv Res Policy. 2008 Oct;13(4):215-21.PMID: 18806179 [PubMed - indexed for MEDLINE]Related articles

[Procedures and methods of benefit assessments for medicines in Germany]

Bekkering GE, Kleijnen J.

Dtsch Med Wochenschr. 2008 Dec;133 Suppl 7:S225-46. Epub 2008 Nov 25. German. PMID: 19034813 [PubMed - indexed for MEDLINE]Related articles

Factors affecting the uptake of new medicines in secondary care - a literature review.

Chauhan D, Mason A.

J Clin Pharm Ther. 2008 Aug;33(4):339-48. Review.PMID: 18613851 [PubMed - indexed for MEDLINE]Related articles

Funding and access to high cost medicines in public hospitals in Australia: decision-makers' perspectives.

Gallego G, Taylor SJ, Brien JA.

Health Policy. 2009 Sep;92(1):27-34. Epub 2009 Mar 9.PMID: 19269709 [PubMed - in process]Related articles

Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003.

Wonder MJ, Neville AM, Parsons R.

Value Health. 2006 Jul-Aug;9(4):205-12.PMID: 16903989 [PubMed - indexed for MEDLINE]Related articles

Improving the use of research evidence in guideline development: 3. Group composition and consultation process.

Fretheim A, Schünemann HJ, Oxman AD.

Health Res Policy Syst. 2006 Nov 29;4:15.PMID: 17134482 [PubMed]Related articlesFree article

What affects asthma medicine use in children? Australian asthma educator perspectives.

Chong JJ, Davidsson A, Moles R, Saini B.

J Asthma. 2009 Jun;46(5):437-44.PMID: 19544161 [PubMed - indexed for MEDLINE]Related articles

What is eHealth (5): a research agenda for eHealth through stakeholder consultation and policy context review.

Jones R, Rogers R, Roberts J, Callaghan L, Lindsey L, Campbell J, Thorogood M, Wright G, Gaunt N, Hanks C, Williamson GR.

J Med Internet Res. 2005 Nov 10;7(5):e54.PMID: 16403718 [PubMed - indexed for MEDLINE]Related articlesFree article

The Pharmaceutical Benefits Scheme 2003-2004.

Harvey KJ.

Aust New Zealand Health Policy. 2005 Jan 12;2(1):2.PMID: 15679896 [PubMed - as supplied by publisher]Related articlesFree article

Security and privacy requirements for a multi-institutional cancer research data grid: an interview-based study.

Manion FJ, Robbins RJ, Weems WA, Crowley RS.

BMC Med Inform Decis Mak. 2009 Jun 15;9:31.PMID: 19527521 [PubMed - indexed for MEDLINE]Related articlesFree article

"It's just routine." A qualitative study of medicine-taking amongst older people in New Zealand.

Tordoff J, Simonsen K, Thomson WM, Norris PT.

Pharm World Sci. 2009 Dec 31. [Epub ahead of print]PMID: 20043241 [PubMed - as supplied by publisher]Related articles